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Introduction: basic 
mechanism of hemostasis and 
thrombosis 
Hemostasis is a complex 
physiological process aiming to keep 
the integrity of a closed circulatory 
system after an occurrence of vessel 
wall injury. Hemostasis involving the 
role of circulating platelets and 
coagulation cascade.1 There are two 
major pathways that act independently 
to activate the platelet. The first 
pathway is mediated by collagen and 
the other by tissue factor. After intimal 
layer injury, platelets are recruited 
through the interaction between 
platelet’s surface glycoprotein (GPVI 
and GPIb/V/IX) with collagen and von 
Willebrand factor. This process results 
in adhesion of platelets in the site of 
injury. Further recruitment of platelets 
is achieved by secretion of aggregatory 
mediators such as thromboxane A2 
and adenosine diphosphate.1,2   
The formation of three dimensional 
platelet clot involving the activation of 
GPIIb/IIIaintegrins. In the setting of 
deeper tissue damage, the activation of 
platelet is mediated by tissue factor 
released predominantly from medial 
and adventitial layer of vessel wall. This 
process generates thrombin from 
prothrombin and activates coagulation 
cascade resulting in fibrin generation.1 
In the physiologic condition, blood 
is maintained in the fluid state by 
certain mechanism. The endothelium 
of vessel wall plays a major role in this 
process by producing antithrombotic 
mediators such as nitric oxide, 
prostacyclin, and the ectonucleotidase 
CD39.1  
The balance of prothrombotic and 
antithrombotic properties of blood and 
vessel wall has to be regulated to 
maintain the closed circulatory system 
but prevent pathologic formation of 
thrombus at the same time. The 
alteration of this balance leads to some 
forms of disease entities. Thrombosis 
is a group of disease characterized by 
pathologic formation of thrombus 
resulting in occlusion of blood vessel.1,3 
Traditionally, the patho- genesis of 
thrombosis is originated from  
interdependent factors: blood stasis, 
vessel wall injury, and hypercoagulable 
state.4  
 
A. Mechanism of arterial 
thrombosis  
Arterial thrombosis frequently 
occurs in the setting of preexisting 
atherosclerotic plaque.2,5,6 Although 
considered as different process, it is 
proposed that the mechanism 
responsible for the formation of 
atherosclerotic plaque is also 
responsible for arterial thrombogenesis 
and vice versa. The formation of 
atherosclerotic plaque is a result of 
interaction between endothelium, 




leukocyte, smooth muscle of vessel 
wall, and certain component of 
adaptive immune response such as 
macrophage. Contrarily, it is 
traditionally accepted that thrombosis 
is a result of activation of platelet and 
coagulation cascade.1,7   
There are evolving concepts that 
propose the mechanism responsible 
for thrombosis involving the role of 
interaction between endothelial cell 
and leukocyte. Furthermore, it has 
been proposed that platelet and certain 
factors of coagulation cascade are 
associated with the progression of 
atherosclerotic plaque.7   
The formation of atherosclerotic 
plaque is a chronic process taking 
years to develop but it is an insidious 
event of plaque rupture that leads into 
an arterial thrombotic episode. After an 
event of plaque rupture or fissuring, 
platelets interact with subendothelial 
matrix which support platelet 
adhesion.7 The adhesion of platelet to 
the site of injury is obtained through 
ligand-receptor binding. Some of 
subendothelial matrix proteins that act 
as ligand are collagen, von Willebrand 
factor, laminin, and fibronectin. Each of 
these ligands bind the specific 
platelet’s surface glycoprotein. 1,5,7  
There is a unique property of the 
ligand favoring the formation of 
thrombus. In arterioles or stenotic 
arteries where the shear stress is high, 
von Willebrand factor has an increasing 
affinity resulting higher amount of 
platelet that can be recruited and 
activated.7,8 Similarly, on the site of 
ruptured atherosclerotic plaque the 
flow is turbulent thus increases the 
shear stress and the affinity of von 
Willebrand factor that in turn activates 
the platelet. Once platelet is activated, 
it recruits more platelet to form a 
platelet-rich white thrombus. Following 
thrombus propagation, the flow is 
decreased at the distal part of 
thrombus creating local condition of 
stasis. It explains the formation of 
erythrocyte-rich red thrombus in the tail 
of the clot.7 
 
B. Mechanism of venous 
thrombosis 
The clinical background of venous 
thrombosis often differs from arterial 
thrombosis.9 A study involving patients 
with spinal cord injury revealed that 
blood stasis plays a major role in the 
formation of venous thrombus. Valvular 
sinus of lower extremity vein is the 
most common site where the thrombus 
originated. A slow blood flow state in 
the valves activates the coagulation 
cascade by allowing the accumulation 
of procoagulant mediator such as 
thrombin.4 In the physiologic state, 
venous valves produce antithrombotic 
proteins such as thrombomodulin and 
endothelin protein C receptor (EPCR) 
to prevent thrombus formation. Venous 
stasis alters this balance by providing a 
microenvirontment favoring thrombus 
formation. Venous stasis is associated 
with decreasing level of oxygen and 
increasing hematocrit. Hypoxic state in 
this microenvirontment halts the 
expression of antithrombotic proteins.10  
Other study involving animal 
model suggested similar mechanism in 
stenotic and compressed vein. This 
may explain thrombosis of the upper 
extremity in the absent of valves. In 
stenotic vein, other mechanism has 
been proposed in terms to explain the 
formation thrombus.11 Endothelial cell 
in stenotic vein is activated and 
producing certain mediators favoring 
the formation of thrombus, a similar 
mechanism to the formation of arterial 
thrombus. Activated endothelium 
expresses von Willebrand factor and 
P-selectin that interact with platelet and 




leukocyte respectively through 
ligand-receptor binding.1,12    
Hypercoagulable state is the 
second factor contributing to the 
formation of venous thrombus. Certain 
conditions are associated with the 
increasing level of coagulation factors 
thus providing a hypercoagulable 
state.10,11 Familial thrombophilia is a 
group of rare disease increasing the 
tendency of thrombosis.3,12 More 
epidemiologically significant causes of 
hypercoagulable state are age, cancer, 
major surgery, pregnancy, hormone 
contraceptive and hormone 
replacement therapy, and obesity. In 
elderly, there is a shifting proportion of 
procoagulant and anticoagulant 
mediator. An increasing level of 
fibrinogen, factor VIII, and factor X is 
not followed by a proportional 
increment of blood anticoagulant 
level.12 Inflammation is thought to be 
the source of procoagulant surge 
following a major surgery beside the 
direct impact to the vascular integrity. 
The expression of tissue factor on 
monocyte and lymphocyte membrane 
is significantly increased 1 day 
following a total knee replacement. 
Pregnancy is also a significant cause of 
hypercoagulable state.12,15 In pregnant 
women, there are increasing fashion of 
factor VII, factor VIII, factor X, 
fibrinogen, and von Willebrand factor. 
Physiogically, this state is providing a 
protection from hemorrhage at the time 
of peripartum and miscarriage. In 
certain cancer, a hypercoagulable state 
is created by secreting a procoagulant 
mediator such as tissue factor or by 
activating signaling pathway through 
lymphocyte or monocyte.12 
Although traditionally proposed 
that venous thrombosis is mainly a 
result of venous stasis and 
hypercoagulable state, current 
evidence shows that vascular injury is 
an important factor in pathogenesis of 
venous thrombosis. Following the 
injury of the intimal layer, von 
Willebrand factor is exposed to the 
platelet similar to the mechanism of 
arterial thrombus formation.12 In the 
fibrotic vein, this process could occur 
without the actual intimal tear. 
Endothelial cell activation could be a 
consequence of intimal injury on 
cellular and molecular level. The 
causes of intimal injury are the 
placement of central venous catheter, 
hemodyalisis catheter, radiation, 
trauma, and extrinsic compression.10,12  
 
C. Arterial vs. venous 
thrombosis: from structure to 
clinical impact 
On cellular and molecular level, it 
has been traditionally proposed that 
there is a distinct structure between 
arterial and venous thrombus. Arterial 
thrombus is suggested to be white 
thrombus meanwhile venous thrombus 
is thought to be red thrombus.13,14 In 
the past few years, there is an evoking 
evidence that the differentiation of 
arterial and venous thrombus is much 
like a matter of proportion rather than 
discrete entities. The structure of both 
thrombi is composed of complex 
structure of fibrin network and cellular 
component such as erythrocyte, 
platelet, and leukocyte.13 Although the 
dichotomy of arterial and venous 
thrombus is important, it has been 
proposed that specific condition which 
the thrombus originated plays major 
role in composition of thrombus.13,14,15 
For instance, older arterial thrombus is 
shown to contain less amount of 
platelet compared to relatively fresh 
thrombus. Similarly as the effect of 
endothelial activation, thrombus 
formed in stenotic upper extremity vein 
is suggested to contain more platelets 




compared to thrombus originated from 
lower extremity which stasis is the main 
contributing factor.10,13,14 
However, the mechanism is clear 
that high shear augments the 
recruitment of platelet thus promoting 
the formation of platelet-rich white 
thrombi and slow flow is associated 
with the generation of erythrocyte-rich 
red thrombi.13   
From the understanding that 
arterial and venous thrombosis shares 
some pathogenesis and pathological 
features albeit the distinct mechanism, 
there are several implications in 
prevention and treatment of patients 
with arterial and venous 
thrombosis.13,14,15 For instance, 
although aspirin is drug of choice in 
treating patient with arterial thrombosis, 
there are well established evidence 
that supports the role of anticoagulant. 
Similarly, there are increasing amount 
of evidences supporting the usage of 
antiplatelet in venous thrombosis.15   
The understanding of thrombus 
structure may also impact clinical 
outcome of fibrinolysis. The mediators 
released by activated platelet lead to a 
more compact fibrin aggregate. It is 
also proposed that those mediators 
inhibit the binding of serine protease to 
fibrin causing the decreasing of its 
activity in degrading fibrin. Those 
mechanism could explain the tendency 
of platelet-rich thrombus to be less 
vulnerable to fibrinolytic agent.16 Finally, 
although there are emerging 
knowledge of pathogenesis and 
structure of arterial and venous 
thrombus, it is still needed to build a 
better approach in managing patient 
with arterial and venous thrombosis. 
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